Methylene Blue for Ifosfamide-Associated Encephalopathy

  • Zulian G
  • Tullen E
  • Maton B
50Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: Ifosfamide is a chemotherapeutic agent used in the treatment of cervical carcinoma, soft-tissue sarcomas, and germ-cell tumors. Myelosuppression is common. Hemorrhagic cystitis is prevented by the administration of mesna. Confusion and coma have been associated with the use of ifosfamide, and antiepileptic drugs may be required.1 Ifosfamide may also cause a dose-dependent encephalopathy in the presence of a pelvic mass that obstructs the ureters or intrinsic renal impairment.2 The drug is marketed in the United States as Ifex (Bristol-Myers Oncology Division, Princeton, N.J.). We report the reversal of ifosfamide-associated encephalopathy with methylene blue in a 68-year-old woman. © 1995, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Zulian, G. B., Tullen, E., & Maton, B. (1995). Methylene Blue for Ifosfamide-Associated Encephalopathy. New England Journal of Medicine, 332(18), 1239–1240. https://doi.org/10.1056/nejm199505043321817

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free